Clinical Trial Update: Residual Paralysis and Reversal With Routine Neostigmine Versus Half-dose Sugammadex and Routine Neostigmine [Phase 4]

View source ↗

Summary

Phase 4 trial comparing residual paralysis reversal with routine neostigmine versus half-dose sugammadex plus routine neostigmine in neuromuscular blockade.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuromuscular Blockade Complications
• Postoperative Residual Curarization

Drugs mentioned

• Neostigmine (neostigmine)
• Sugammadex (sugammadex)

Snippet

Sponsor: Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital | Conditions: Neuromuscular Blockade, Sugammadex | Phase 4 | Status: COMPLETED